Following the pulsation protocol, we observed increased VLD- and RMF-specific CD8 + T-cells in healthy control samples (the proportion of WT1-specific T-cells prior to pulsation, not available from AML patients) (Fig. 1B, Supplemental Fig. 1B). Here, CD8A is linked to acute myeloid leukemia.